Aim: To provide national consensus on the range of conditions community practitioner nurse prescribers manage and for which it is considered important that they can prescribe.
| INTRODUCTION
Extending nurses' scope of practice to include prescribing has been supported in several countries, including the UK, the USA, New Zealand, Netherlands, Ireland, Australia, Canada and Sweden (Ball, Barker, & Buchanan, 2009; Kroezen, Van Dijk, Groenewegen, & Francke, 2011; Weeks, George, Maclure, & Stewart, 2016) . Drivers for this role include the need to address doctor shortages, improve patient access to medicines, make better use of nurses' skills and to develop advanced practitioner roles (Kroezen et al., 2011; Weeks et al., 2016) .
In the UK, changes in legislation in 1992, enabled District Nurses supplementary prescribing is typically 6 months in length (NMC 2006) . This is in contrast to countries such as the United States, Canada and Australia, where training to independently prescribe is at master's level for registered nurses and a component of 2-year advanced nurse practitioner programmes (Ball et al., 2009 ).
Although there is evidence available that has explored the prescribing practices of nurse independent supplementary prescribers, there is very little recent evidence available that has explored the prescribing practices of community practitioner nurse prescribers (CPNPs). The evidence that is available has reported that whilst these nurses view prescribing as an important element of their role (Downer & Shepherd, 2010; Young, 2009) , decreasing numbers are actively prescribing (Drennan, Grant, & Harris 2014) with reports that items included in the NPF do not meet the needs of the patients these nurses manage (Brooks, Otway, Rashid, Kilty, & Maggs 2001; Hall, Cantrill, & Noyce, 2006; Lewis-Evans & Jester 2004; While & Biggs, 2004) . This is concerning given that prescribing has been identified as a key role for community nurses (Health Education England 2015 , NHS England 2014 .
| BACKGROUND
Nurse independent and supplementary prescribers, of whom there are 36,000 in the UK (M. Courtenay, personal communication, 2017) , prescribe for a broad range of conditions (Courtenay et al., 
Why is this research needed?
Prescribing is a key role for community nurses, however, there has been a decline in the numbers of these nurses who prescribe from the limited range of items available to them in the Nurse Prescribers Formulary for Community Practitioner Nurse Prescribers.
Although it is evident that the changing pattern of client and service delivery has changed the role of the community nurse, little evidence is available about the conditions community practitioners nurse prescribers manage.
What are the key findings?
Overall, the modified Delphi method used in this study enabled panelists to reach a consensus, with consistent high levels of agreement reached, on nineteen conditions for which it is believed community nurse practitioner prescribers should be able to prescribe.
Consensus was achieved by district nurses and community staff nurses on several chronic conditions, whereas agreement was reached on several more acutely focused conditions across all community practitioner prescriber groups.
How should the findings be used to influence policy/practice/research/education?
The conditions identified in this research provide national guidance on the items community practitioner nurse prescribers need to prescribe and also international guidance for countries where prescribing by community and public health nurses is established and for those countries wishing to establish prescribing by these nurses.
Our findings can also be used to direct national and international education and training for the preparation of community and public health nurses. 2017; Latter et al., 2010) . They are safe and prescribe clinically appropriate medicines (Latter et al., 2005 (Latter et al., , 2010 . Stakeholders are satisfied (Courtenay, Carey, Stenner, Lawton, & Peters, 2011; Latter et al. 2010 ) and outcomes of care are comparable to medical prescribing (Gielen, Dekker, Francke, Mistiaen, & Kroezen, 2014; Weeks et al., 2016) . Between 10% and 20% of CPNPs have been reported to go on to become nurse independent supplementary prescribers (Courtenay, Carey, & Stenner, 2012; Courtenay et al., 2017; Latter et al., 2010) .
Most studies that have explored prescribing by CPNPs were undertaken over a decade ago. A review of the literature in 2004 (Latter & Courtenay, 2004) , designed to identify the impact and effectiveness of community practitioner nurse prescribing, reported that although prescribing by these nurses had generally been evaluated positively, there was wide variation in the number of items prescribed, with DNs prescribing more than HVs. A consistent theme in the 18 studies included in the review, was that the NPF was restrictive, with both nurses and patients calling for expansion to the range of medicines that nurses were able to prescribe. Following on from this review, low levels of prescribing amongst CPNPs have been reported (Courtenay et al., 2012; Drennan, et al., 2014; Hall et al., 2006) . Hall et al. (2006) , in interviews with 23 CPNPs and 5 prescribing leads in primary care trusts in three strategic health authorities, identified 16% of these nurses prescribed infrequently (i.e. less than once a week) with double the proportion of HVs compared with DNs classed as infrequent prescribers. Furthermore, the inability by these nurses to prescribe medicines for patients they managed was reported to be a barrier to prescribing. Findings from a survey of nurse, pharmacist and allied health professional prescribers in one strategic health authority reported as many as a third of CPNPs did not prescribe (Courtenay et al., 2012) . This finding was supported in a later study by Drennan et al. (2014) Evidence available (Nissanholtz-Gannot, Rosen, & Hirschfeld, 2017; Roden, Jarvis, Campbell-Crofts, & Whitehead 2016 , Maijala, Tossavainen, & Turunen, 2016 Kelehera & Parker, 2013; Kemp, Harris, & Comino, 2005) , has identified a shift in focus of the care provided by these nurses. In Australia, for example, researchers have reported community nurses to be increasingly working in roles that have moved away from longer term support and care to provision of a more "acutely" focussed episodic care (Kemp et al., 2005) with increasing involvement in health promotion activities (Kelehera & Parker, 2013; Roden, et al., 2016) . Similarly, in Finland and Israel, researchers have reported nurse's involvement in the implementation of a variety of health educational activities in the primary healthcare context (Maijala et al., 2016 ) and a shift in nursing tasks from hospitals to the community setting, a key area of involvement, including health promotion (Nissanholtz-Gannot et al., 2017) .
Given the increased investment in the UK in the skills of community nurses, including prescribing (HEE, 2016 , NHS England 2014 , it is important that these nurses are able to prescribe medicines for the conditions they manage. The items listed in the NPF have remained unchanged since its inception in 1998 and it is likely, given the changing population profiles and changing patterns of client and service delivery, that these items no longer reflect the prescribing needs of these nurses. To our knowledge, there is no evidence available that has explored the conditions these nurses manage.
| TH E STUDY

| Aim
The aim of this research was to provide national consensus on the range of conditions CPNPs manage and for which it is considered important that they can prescribe.
| Design
Where there is an absence of research evidence or the desire to gather opinion, structured or formal methods are commonly used to reach consensus. The Delphi technique is a commonly used formal consensus method which uses an iterative series (or rounds) of questionnaires to gather data and achieve group consensus (Keeney, Hasson, & McKenna 2011) . A benefit of the Delphi technique is the potential to include large numbers of participants who are geographically dispersed and are from diverse areas of expertise (Keeney et al. 2011) . The technique, unlike traditional group meetings, avoids the risk of meetings being dominated by one individual or influenced by coalitions between group members (Keeney et al. 2011) . A classic Delphi survey begins with a questionnaire containing open-ended questions from which subsequent questionnaires are developed (Day & Bobeva, 2005 ; Hasson, Keeney, & McKenna, 2000) . As a list of conditions for which CPNPs are reported to manage had already been developed from the literature, the current study used a modified Delphi survey, i.e. the tra-
ditional round 1 open-ended questionnaire was replaced with this predefined list of conditions. This is an acceptable modification of the Delphi process (Keeney et al., 2011) .
| Participants
The Delphi technique employs "experts" as panel members as opposed to a random sample representative of the target population.
However, there is a lack of consensus in the literature as to the definition of an expert (Baker, Lovell, & Harris, 2006) and no consensus as to the optimum number of participants to be included in Delphi
surveys (Keeney et al., 2011) . It is suggested that the selection of expert panel members should be dependent on what is being investigated, the complexity of the problem, the homogeneity or heterogeneity of the sample and availability of resources (Keeney et al., 2011) . Although there is no consensus in the literature as to what is defined as large or small, larger panels are recommended for heterogenous groups and smaller panels for homogenous groups (Skulmoski, Hartman, & Krahn, 2007) . Larger samples are reported to increase the complexity and difficulty of collecting data, reaching consensus, conducting analysis and verifying results (Skulmoski et al., 2007) and it is recommended that researchers be explicit about criteria used to include participants in a study (Trevelyan & Robinson, 2015) . Given the topic being investigated and resource constraints, the decision was made to include a relatively homogenous sample (i.e. recruiting only CPNPs) and "Expert" for the current Delphi study was defined as specialist community practitioners with a prescribing qualification and CSNs (without a specialist qualification) qualified to prescribe.
Participants of the expert panel were recruited through a purposive sampling method to create a database reflecting the range of community nurses able to prescribe medicines from the NPF for community practitioners. To ensure that the full range of these nurses was included on the panel and that they were representative of CPNPs across the UK, contact was made by MC with Chief Exec- Prescribers. These individuals were informed about the project and provided with details about the research. They were also invited to share these details with their members. Specialist Community Practitioners with a prescribing qualification and CSN prescribers (without a specialist qualification) were invited to contact the researchers, if they were keen to become an expert member of the Delphi panel.
The current survey aimed to include all professionals who expressed an interest to take part and who fulfilled our definition of "expert".
One hundred and fifty community nurses contacted the researchers and expressed an interest to participate. Each was sent a participant information sheet by email and provided with the opportunity to address any queries they may have had with a researcher.
The participant information sheet highlighted that questionnaire data would be anonymous, that all information collected during the study would be kept strictly confidential and that completion of questionnaires provided implied consent to participate. Of the 150 community nurses who expressed an interest to take part, 89 community nurses agreed to participate.
| Data collection and analysis
The survey was conducted across three rounds. Bristol Online Survey-a tool for creating web surveys-was used to develop each round of the on-line questionnaire survey. A link to each survey was distributed via email to all participants who had confirmed their participation, followed by two follow-up reminder emails, at one week intervals per survey round. Data collection took place between January and March 2017.
| Round 1-Elicitation of the conditions managed by community practitioner prescribers
A list of 15 conditions for which CPNPs are reported to manage, was developed from the literature (Table 1) . Delphi panel members were asked to identify from this list, the conditions they manage, prescribe for, treat, or provide advice. Space was also provided for panel members to list any additional conditions not included on the list. Demographic details collected included the role, if they were a qualified nurse independent supplementary prescriber, job band, employer, years qualified as a prescriber, age range, setting where participant worked, service provided, whether participants prescribed and the number of items prescribed per month, was also collected.
| Refining factors and actions
Questionnaire data were analysed in SPSS version 17 and descrip- 
| Round 2-Building consensus on priorities
An email was sent to members of the expert panel inviting them to participate in round 2 of the Delphi process. In this round, participants were asked to use a five-point Likert scale (1 = strongly agree to 5 = strongly disagree) to rate each condition identified in round 1, with regards to the extent to which they felt it was important that they could prescribe for it. Median scores and interquartile ranges (IQRs) were calculated for responses to each condition, for each community nurse group (i.e. DNs, HVs, SNs and CSNs), to characterize the answer category above and below which 50% of the answers fell. IQRs which form the distance between the 25th and 75th percentiles were used to represent the spread of the data and to assess the level of consensus per question. Although there is no agreement on the best method used to determine consensus, median score and IQR is a frequently used method (Skulmoski et al., 2007) and is considered robust (Stark et al., 2016) . Responses where the median was less than or equal to 2 (i.e. a high level of agreement that participants viewed it as important to their role that they can prescribe for this condition) with a small IQR (≤1.5), were considered important conditions that have reached consensus across each community practitioner group and taken forward to round 3 .
| Round 3-Reaching consensus on priorities
In the final round, participants were asked to rank each condition with regard to how much of a priority it was that they were able to T A B L E 3 Demographic details of those responding to round 1 Due to missing data from participants who chose not to disclose demographic information, the percentages do not always equal 100%. Some respondents worked across both primary and secondary care settings, and provided more than one service, therefore, these percentages do not equal 100%.
prescribe for it. Responses were inversely scored and collated. Priorities were defined as the conditions receiving the highest total scores for each group.
| Ethical consideration
Ethical approval for the study was provided by the School of Healthcare Sciences Research Governance and Ethics Committee, Cardiff University (427c).
| RESULTS
A total of 89 CPNPs agreed to become members of the expert panel, of whom 80 (90%) completed the round 1 questionnaire, 70/ 80 (88%) completed Round 2 and 65/70 (92%) responded to round 3. Table 2 provides a description of the different types of CPNP who responded to each round (see Figure 1 for a summary of the Delphi process).
| Round 1
Eighty (90%) participants responded to the initial survey. Most of these participants were HVs. Only small numbers were SNs (see Table 2 ). Forty-one (51.3%) participants had more than 5 years' experience as a qualified prescriber and 67 (83.8%) participants reported that they prescribed. The demographic characteristics of these participants are described in Table 3 . A list of 30 conditions were identified by respondents as those for which they managed, prescribe for, treat, or provide advice (see Table 4 ).
| Round 2
Seventy (88%) participants responded to the second round. See Table 5 for a description of the median scores and IQRs for each of the 30 conditions per CPNP group. Responses from DNs identified nine conditions, for which there was a high level of agreement, that it was important to their role that they could prescribe medicines.
HVs showed a high level of agreement across seven conditions. SNs agreed on 12 conditions and CSNs six conditions. These conditions were taken forward into round 3.
| Round 3
Sixty-five (92%) participants responded to the third round. Conditions, ranked in priority order (for each group), are presented in Table 6 .
| DISCUSSION
The aim of this study was to provide national consensus on the range of conditions CPNPs manage and for which it is considered important that they can prescribe. Starting with a predetermined list of conditions developed from the literature, the traditional round 1 of the Delphi survey i.e. item generation was unnecessary. Overall, the modified Delphi method used in this study enabled panelists to reach a consensus, with consistent high levels of agreement reached, on nineteen conditions. This included five additional conditions (skin infections, lymphoedema, postimmunization fever, infant colic and nocturnal enuresis) contributing to round 2. Confidence in reaching consensus means that we now have a comprehensive list of conditions for which each group of CPNPs believe it is important for them to be able to prescribe.
In line with previous research (Daughtry & Hayter, 2010; Downer & Shepherd, 2010; Herklotts, Baileff, & Latter, 2015 Conditions identified by HVs (such as infestation, fungal infections, dry skin) supports the results of previous research (Ellefsen, 2001 ) that HVs have a significant role in health promotion and early intervention and aligns with the role HVs play in supporting parents and carers to recognize and act on childhood illnesses (NHS England 2014). Contraception and sexual health and smoking cessation, rated as priority areas by SNs, concurs with themes identified in research by UK researchers Hoekstra, Young, Eley, Hawking, and McNulty (2016) . This also corresponds to national guidance where a key role of these nurses is to reduce under 18 conceptions, reduce smoking prevalence and chlamydia diagnosis (Public Health England, 2014).
Although DNs and CSNs primarily identified chronic conditions as those for which they believed they needed to prescribe, several acute conditions were also identified. This aligns with the complex care needs of the patients these nurses have been reported to manage in the UK (Queens Nurse Institute 2014). Our findings also align with the international research that has explored community and public health nursing roles in countries including Australia (Kelehera & Parker, 2013; Kemp et al., 2005; Rodden et al., 2016) , Finland (Maijala et al., 2016) , the US (Schaffer, Anderson, & Rising, 2016) and Israel (Nissanholtz-Gannot et al., 2017) , the findings of which report the increasing involvement of these nurses in acute episodic care and health promotion activities.
Although participants in our study believed it was important that they were able to prescribe, they typically only prescribed a small number of items a month which supports earlier evidence (Hall et al., Shaded areas signify the conditions for which there was high level of agreement amongst the different CPNP groups, that it was important to their role that they could prescribe medicines.
2006; While & Biggs, 2004) . This may suggest that prescribing knowledge is applied in other ways than physically writing a prescription which aligns with previous research (Courtenay et al., 2012 (Courtenay et al., , 2017 Herklotts et al., 2015) , nurses reporting that they use their prescribing knowledge to undertake a range of other activities such as making recommendations to another healthcare professional to prescribe a medicine or, making recommendations to a patient to buy a medication over the counter and medicines reviews.
Given the increased investment in the skills of community and public health nurses globally, our findings should be of international interest. Strategies are required to address health service demands in low-, middle-and high-income countries, extending nurses scope of practice to include prescribing is one such strategy. Strengthening nurses' capacity in this way improves their ability to reach more people with quality health services (Weeks et al., 2016) . Although it is recognized that the findings of this work originate from a UK perspective and so leaves open the need for adaptation to other healthcare systems and consideration of other national and regional concerns, our findings provide some guidance for those countries where prescribing by community and public health nurses is established and for those countries wishing to establish prescribing by these nurses, with regards to the conditions these nurses manage and so the medicines they will need to prescribe. Our findings can also be used to direct national education and training for the preparation of community and public health nurses. If proposals (NMC 2017), enabling community nurses to access training to prescribe immediately on qualifying as a 1st level registered nurse are accepted, it will also be important to include some of this preparation in undergraduate nurse education programmes.
Findings from this study could be used to inform further survey work, involving a larger sample of CPNPs, or, patients and other members of the community healthcare team. This would help to validate study findings and so may have a greater influence on policy.
Another important next step would be to investigate how prescribers decide whether to expand their prescribing competencies to new areas of practice, perhaps moving on to undertake nurse independent and supplementary prescribing training. Less than 10%
of the CPNPs in our study were qualified as nurse independent and supplementary prescribers and this is fewer than the figures of between 10%-20% reported previously (Courtenay et al., 2012 (Courtenay et al., , 2017 Latter et al., 2010) . If training interventions, designed to help these prescribers feel confident to identify areas of practice where they would like to expand their prescribing competencies, could be identified, this has the potential to lead to improved patient experience and cost savings for the NHS.
| LIMITATION S
The main strength of our work is that it is based on responses from a national panel of defined experts, had a good response rate and provides information on the range of conditions that CPNPs manage and for which it is considered important that they can prescribe.
However, some limitations also need to be recognized. First, although expert panel members who responded to each Delphi round, included each of the different groups of CPNPs, only small numbers were SNs. Therefore, our findings may not present an accurate picture of this population rather, they may represent the views of DNs, HV and CSN prescribers. Second, we could have included other groups on the expert panel e.g. doctors and patients. We acknowledge that for care to be patient centred, patients need to participate in the research that informs healthcare decisions, however, given resource constraints and the, problems associated with large heterogenous samples (i.e. difficulties surrounding data collection/analysis, reaching consensus and verifying results) (Skulmoski et al., 2007) , the decision was made to include only CPNP on the expert panel. As such, our findings may not be representative of the wider population. 
